Dr. Terry Kenakin is Professor of Pharmacology at the University of North Carolina School of Medicine. Prior to this, he spent 7 years in drug discovery at Burroughs-Wellcome. He then moved to GlaxoSmithKline for 25 years.
Dr. Kenakin has written 11 books on Pharmacology, is the Editor in Chief of the Journal of Receptors and Signal Transduction, is on numerous Editorial Boards, and has written many reviews and original papers on pharmacology.
Dr. Kenakin received his BSc in Chemistry and PhD in Pharmacology from the University of Alberta. He conducted a post-doctoral Fellowship at University College in England.